Literature DB >> 25607562

Comparison of the efficacy of long-pulsed Nd:YAG laser intervention for treatment of onychomycosis of toenails or fingernails.

Yan Li, Sisi Yu, Jing Xu, Ruina Zhang, Junying Zhao.   

Abstract

BACKGROUND: Current studies have demonstrated the efficacy and safety of laser intervention in the treatment of onychomycosis. The objective of this study was to compare the efficacy of long-pulsed Nd:YAG 1064 nm laser for treatment of toenails onychomycosis with fingernails onychomycosis.
METHODS: One hundred and twelve affected fingernails or toenails in 37 patients with onychomycosis were randomized into Group 1 (22 patients with 50 affected fingernails) and Group 2 (15 patients with 62 affected toenails). These patients were further classified into three subgroups (Grade II, III, and IV) according to Scoring Clinical Index of Onychomycosis. All the affected nails were treated with long-pulse Nd:YAG 1064 nm laser intervention, once weekly, for continuous weeks, and were followed up for 24 weeks.
RESULTS: The response rates at weeks 8, 16, and 24 were 0, 0 and 52%, respectively, for Group 1, and 10, 32 and 71% for Group 2. The inter-group difference in efficacy was statistically significant (P<0.05). Even in the same subgroup, the response rate of Group 2 was higher than that of Group 1.
CONCLUSIONS: The efficacy of long-pulsed Nd:YAG 1064 nm laser intervention against affected toenails is superior to that against fingernails. It is also effective for treatment of onychomycosis with different severity.

Entities:  

Mesh:

Year:  2014        PMID: 25607562

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  9 in total

1.  Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer.

Authors:  Jing Zhang; Sha Lu; Huaiqiu Huang; Xiqing Li; Wenying Cai; Jianchi Ma; Liyan Xi
Journal:  Lasers Med Sci       Date:  2016-06-23       Impact factor: 3.161

2.  1340nm LASER THERAPY FOR ONYCHOMYCOSIS: Negative Results of Prospective Treatment of 72 Toenails and a Literature Review.

Authors:  Graciela Araújo Do Espírito-Santo; Diniz Pereira Leite; Hugo Dias Hoffmann-Santos; Luciana Basili Dias; Rosane Christine Hahn
Journal:  J Clin Aesthet Dermatol       Date:  2017-08-01

3.  Efficacy of Two-Stage Treatment of Onychomycosis Using a Long-Pulsed Nd:YAG 1064-nm Laser.

Authors:  Shan Zhong; Guan-Ting Lin; Jun-Ying Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-16       Impact factor: 2.629

4.  Laser treatment for onychomycosis: A systematic review and meta-analysis.

Authors:  Weiwei Ma; Chenchen Si; Lorna Martin Kasyanju Carrero; Hou-Fang Liu; Xu-Feng Yin; Juan Liu; Yang Xu; Bingrong Zhou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Topical and device-based treatments for fungal infections of the toenails.

Authors:  Kelly Foley; Aditya K Gupta; Sarah Versteeg; Rachel Mays; Elmer Villanueva; Denny John
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16

6.  Self-controlled Study of Onychomycosis Treated with Long-pulsed Nd:YAG 1064-nm Laser Combined with Itraconazole.

Authors:  Yan Li; Jing Xu; Jun-Ying Zhao; Feng-Lin Zhuo
Journal:  Chin Med J (Engl)       Date:  2016-08-20       Impact factor: 2.628

Review 7.  Onychomycosis: A Review.

Authors:  Bianca Maria Piraccini; Aurora Alessandrini
Journal:  J Fungi (Basel)       Date:  2015-03-27

8.  Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: a single-center, retrospective analysis in 56 patients.

Authors:  G C Weber; P Firouzi; A M Baran; E Bölke; H Schrumpf; B A Buhren; B Homey; P A Gerber
Journal:  Eur J Med Res       Date:  2018-10-24       Impact factor: 2.175

Review 9.  Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials.

Authors:  Julianne M Falotico; Rebecca Lapides; Shari R Lipner
Journal:  J Fungi (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.